Seelos Therapeutics, Inc.: cashflow_financing

Value{"amount": -1597000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntitySeelos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-23-030733 · Open the official SEC filing →
Retrieved: 2026-08-19T09:53:15.866234+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001017491/cashflow-financing/2022-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f1ded121-6918-4e6d-8f2e-eb6a1845853d

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies